Xiaodong Wang - 04 Mar 2025 Form 4 Insider Report for BeiGene, Ltd. (ONC)

Signature
/s/ Qing Nian, as Attorney-in-Fact
Issuer symbol
ONC
Transactions as of
04 Mar 2025
Net transactions value
-$2,073,826
Form type
4
Filing time
06 Mar 2025, 16:48:22 UTC
Previous filing
06 Feb 2025
Next filing
13 Mar 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BGNE American Depositary Shares Sale $176,193 -700 -8.6% $251.70 7,446 04 Mar 2025 See Footnote F2, F4, F5
transaction BGNE American Depositary Shares Sale $505,431 -2,000 -27% $252.72 5,446 04 Mar 2025 See Footnote F2, F4, F6
transaction BGNE American Depositary Shares Sale $209,180 -825 -15% $253.55 4,621 04 Mar 2025 See Footnote F2, F4, F7
transaction BGNE American Depositary Shares Sale $324,836 -1,275 -28% $254.77 3,346 04 Mar 2025 See Footnote F2, F4, F8
transaction BGNE American Depositary Shares Sale $310,435 -1,214 -36% $255.71 2,132 04 Mar 2025 See Footnote F2, F4, F9
transaction BGNE American Depositary Shares Sale $464,607 -1,809 -85% $256.83 323 04 Mar 2025 See Footnote F2, F4, F10
transaction BGNE American Depositary Shares Sale $83,144 -323 -100% $257.41 0 04 Mar 2025 See Footnote F2, F4, F11
holding BGNE Ordinary Shares 5,240,882 04 Mar 2025 Direct
holding BGNE Ordinary Shares 1,025,063 04 Mar 2025 See Footnote F1
holding BGNE Ordinary Shares 3,953,100 04 Mar 2025 See Footnote F2
holding BGNE Ordinary Shares 50 04 Mar 2025 See Footnote F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 These securities are held by a family trust, the beneficiaries of which are the Reporting Person's family members, for which the Reporting Person disclaims beneficial ownership.
F2 These securities are held by Wang Investment LLC, of which 99% of the limited liability company interest is owned by two grantor retained annuity trusts, of which the Reporting Person's wife is a trustee, for which the Reporting Person disclaims beneficial ownership.
F3 These securities are held by the spouse of the Reporting Person.
F4 The sale was effected pursuant to a Rule 10b5-1 trading plan adopted on August 12, 2024.
F5 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $251.15 to $252.11, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.
F6 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $252.18 to $253.16, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.
F7 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $253.23 to $254.21, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.
F8 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $254.24 to $255.11, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.
F9 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $255.36 to $256.34, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.
F10 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $256.37 to $257.28, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.
F11 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $257.37 to $257.43, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.